Predictors of Death, Discharge ID ’ d for Diabetes Patients With COVID - 19
Younger age, routine metformin therapy, and longer symptom duration on admission positively linked to discharge (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - February 23, 2021 Category: Respiratory Medicine Tags: Endocrinology, Infections, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Pharmacy, Pulmonology, Geriatrics, Journal, Source Type: news

Metformin for Diabetes Has No Effect on COVID-19 Infection, Death Metformin for Diabetes Has No Effect on COVID-19 Infection, Death
With propensity score matching and inclusion of nonhospitalized primary care patients, metformin use did not influence COVID-19 susceptibility or mortality in those with diabetes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 17, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Study Looks at T2DM, Metformin Use, and Breast Cancer Risk
Links between T2DM with metformin use and breast cancer risk appear to be affected by hormone receptor status (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 10, 2021 Category: Cancer & Oncology Tags: Endocrinology, Family Medicine, Gynecology, Internal Medicine, Oncology, Pharmacy, Journal, Source Type: news

Study Looks at T2DM, Metformin Use, and Breast Cancer Risk
WEDNESDAY, Feb. 10, 2021 -- The risks for breast cancer in women with type 2 diabetes (T2D) may be influenced by long-term metformin use, according to a study published online Jan. 28 in the Annals of Oncology. Yong-Moon Mark Park, M.D., Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 10, 2021 Category: Pharmaceuticals Source Type: news

Long-Term Metformin Use Linked to Fewer ER+ Breast Cancers Long-Term Metformin Use Linked to Fewer ER+ Breast Cancers
Observational data from over 40,000 women with type 2 diabetes documents fewer estrogen receptor-positive breast cancers in those treated with metformin long-term; editorialists question conclusions, however.Medscape Medical News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - February 3, 2021 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Metformin Tied to Longer Gestation in Women With Preeclampsia Metformin Tied to Longer Gestation in Women With Preeclampsia
The small study does not suggest it ' s time for any clinical practice changes but provides evidence that it may be possible to reduce preterm births due to preeclampsia.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 2, 2021 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Diabetes Drug Metformin Could Help Prevent Breast Cancer
Title: Diabetes Drug Metformin Could Help Prevent Breast CancerCategory: Health NewsCreated: 2/1/2021 12:00:00 AMLast Editorial Review: 2/2/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 2, 2021 Category: Cancer & Oncology Source Type: news

Type 2 Diabetes Drug Metformin Could Help Prevent Some Breast Cancers
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 2, 2021 Category: Cancer & Oncology Tags: Gynecology, Oncology, Diabetes, News, Source Type: news

Metformin Could Help Prevent Some Breast Cancers
Women with type 2 diabetes may be more likely to develop breast cancer, but taking the diabetes drug metformin appears to reduce their risk for the most common type, new research finds. (Source: WebMD Health)
Source: WebMD Health - February 1, 2021 Category: Consumer Health News Source Type: news

Type 2 Diabetes Drug Metformin Could Help Prevent Some Breast Cancers
MONDAY, Feb. 1, 2021 -- Women with type 2 diabetes may be more likely to develop breast cancer, but taking the diabetes drug metformin appears to reduce their risk for the most common type, new research finds. Compared to women without diabetes,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 1, 2021 Category: General Medicine Source Type: news

Metformin may affect risk of breast cancer in women with type 2 diabetes
(European Society for Medical Oncology) A study in Annals of Oncology of 44,541 women has found that there appears to be no association between type 2 diabetes and developing breast cancer overall. This may be because most women in the study with type 2 diabetes were taking metformin, a medication widely used to treat type 2 diabetes, whose actions may help to reduce the risk of developing oestrogen positive (ER-positive) breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 28, 2021 Category: Cancer & Oncology Source Type: news

Metformin Use for T2DM May Reduce COVID - 19 Mortality
Odds of contracting COVID - 19, COVID - 19 - related mortality higher for individuals with diabetes (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - January 27, 2021 Category: Respiratory Medicine Tags: Endocrinology, Family Medicine, Geriatrics, Gynecology, Infections, Internal Medicine, Critical Care, Nursing, Pharmacy, Pulmonology, Journal, Source Type: news

Metformin Use for T2DM May Reduce COVID-19 Mortality
WEDNESDAY, Jan. 27, 2021 -- Diabetes is associated with increased odds of contracting COVID-19 and with increased COVID-19 mortality, while metformin treatment before diagnosis of COVID-19 is associated with reduced odds of related mortality,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2021 Category: Pharmaceuticals Source Type: news

Nostrum Laboratories, Inc. Expands Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 750 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit
Nostrum Laboratories, Inc. is voluntarily recalling one lot of Metformin HCl Extended Release Tablets, USP 750 mg (generic equivalent to Glucophage Tablets) to the consumer level. The Metformin HCl Extended Release Tablets, USP 750 mg (generic equivalent to Glucophage Tablets) have been found to con (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 25, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Metformin Treatment Again Linked to Fewer Deaths From COVID-19 Metformin Treatment Again Linked to Fewer Deaths From COVID-19
The latest of several studies, this time in a very diverse population, shows a striking threefold reduction in deaths from COVID-19 in those taking this leading treatment for type 2 diabetes.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 20, 2021 Category: Intensive Care Tags: Infectious Diseases News Source Type: news